In the busy rhythm of clinical practice, the interaction between physicians and medical representatives remains a constant. While these exchanges bring valuable updates on new formulations and clinical data, they can also subtly shape prescribing behavior — sometimes beyond evidence-based needs. In a time when polypharmacy, antibiotic overuse, and cost-conscious care are growing concerns, physicians must reassert clinical independence as the cornerstone of rational prescribing. Balancing information with interpretation is key.
Every visit from a representative should be viewed as an opportunity to cross-check claims against guidelines and peer-reviewed evidence. Doctors can empower themselves by asking for trial data, safety updates, and cost comparisons, rather than brand narratives. By anchoring every prescription in the patient context (comorbidity, affordability, and adherence),…
